Lymphoma
This year, an estimated 62,250
people in the United States will be diagnosed with lymphoma.
These include 7,880 cases of Hodgkin’s disease and
54,370 cases of non-Hodgkin’s lymphoma.
Treatments
for these disorders vary and may include radiation therapy,
chemotherapy, high-dose chemoradiotherapy and/or blood and marrow
transplantation. These
treatments have helped increase the 5-year survival rate to 84% for Hodgkin’s disease and
56% for
non-Hodgkin’s lymphoma.
Blood and
marrow transplantation offers the greatest hope for patients who are
at high risk, or who have relapsed.
The Transplant Program at University Hospitals has
significant expertise and experience in the treatment of
lymphoma in this manner. Clinical
trials are exploring new antibody treatments, various
chemotherapy regimens, and targeted therapies.
More
Information:
Lymphoma
Blood and Marrow Transplant Program
Clinical Trials for Lymphoma
Support Services
Important Phone Numbers |
